Stay updated on Pembro and Vorinostat in Stage IV NSCLC Clinical Trial
Sign up to get notified when there's something new on the Pembro and Vorinostat in Stage IV NSCLC Clinical Trial page.

Latest updates to the Pembro and Vorinostat in Stage IV NSCLC Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedFooter/credits now include the Moffitt Cancer Center Clinical Trials website and the full institutional name, and the site revision is updated from v3.6.0 to v3.6.3.SummaryDifference0.2%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page now reflects that recruitment has ceased for participants, indicating the study is not actively enrolling. Added help and navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) along with minor formatting changes to the Intervention/Treatment label and a revision tag updated to v3.6.0.SummaryDifference0.4%

- Check30 days agoChange DetectedThe page's revision stamp was updated from v3.5.4 to v3.5.5. This update modifies version metadata and does not change study details or user-visible content.SummaryDifference0.1%

- Check51 days agoChange DetectedFooter branding and versioning were updated: a new revision badge (Revision: v3.5.4) was added. Several footer lines referencing the sponsor/organization and the previous revision tag (Revision: v3.5.3) were removed.SummaryDifference0.2%

- Check73 days agoChange DetectedThe page’s revision/version indicator was updated from “v3.5.2” to “v3.5.3,” reflecting a site or display update rather than a change to the trial information.SummaryDifference0.1%

- Check80 days agoChange DetectedSite revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

Stay in the know with updates to Pembro and Vorinostat in Stage IV NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembro and Vorinostat in Stage IV NSCLC Clinical Trial page.